Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
0.40%69.770.8%$494.40m
ISRGIntuitive Surgical, Inc.
-0.40%501.412.4%$493.80m
MDTMedtronic PLC
0.40%92.440.6%$468.45m
TMOThermo Fisher Scientific Inc.
0.66%236.561.0%$454.95m
ALGNAlign Technology, Inc.
0.90%221.306.3%$432.09m
BDXBecton, Dickinson and Company
0.83%236.441.1%$315.64m
EWEdwards Lifesciences Corporation
0.53%149.031.2%$285.48m
BAXBaxter International Inc.
1.66%64.081.7%$283.89m
BSXBoston Scientific Corporation
-0.60%36.441.1%$281.21m
ABMDABIOMED, Inc.
-5.24%313.293.3%$231.86m
SYKStryker Corporation
-0.58%166.841.3%$231.77m
DXCMDexCom, Inc.
-2.31%139.438.5%$179.86m
ZBHZimmer Biomet Holdings, Inc.
0.09%113.011.7%$146.02m
WATWaters Corporation
0.41%196.693.4%$141.89m
IDXXIDEXX Laboratories, Inc.
-0.30%198.243.7%$123.69m

Company Profile

Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.